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Pharmacological Characterization of a Tyramine Receptor from the
Southern Cattle Tick, Rhipicephalus (Boophilus) microplus
Abstract
The southern cattle tick (Rhipicephalus (Boophilus) microplus) is a hematophagous external parasite that
vectors the causative agents of bovine babesiosis or cattle tick fever, Babesia bovis and B. bigemina, and
anaplasmosis, Anaplasma marginale. The southern cattle tick is a threat to the livestock industry in many
locations throughout the world. Control methods include the use of chemical acaricides including amitraz, a
formamidine insecticide, which is proposed to activate octopamine receptors. Previous studies have identified
a putative octopamine receptor from the southern cattle tick in Australia and the Americas. Furthermore, this
putative octopamine receptor could play a role in acaricide resistance to amitraz. Recently, sequence data
indicated that this putative octopamine receptor is probably a type-1 tyramine receptor (TAR1). In this study,
the putative TAR1 was heterologously expressed in Chinese hamster ovary (CHO-K1) cells, and the
expressed receptor resulted in a 39-fold higher potency for tyramine compared to octopamine. Furthermore,
the expressed receptor was strongly antagonized by yohimbine and cyproheptadine, and mildly antagonized
by mianserin and phentolamine. Tolazoline and naphazoline had agonistic or modulatory activity against the
expressed receptor, as did the amitraz metabolite, BTS-27271; however, this was only observed in the
presence of tyramine. The southern cattle tick's tyramine receptor may serve as a target for the development of
anti-parasitic compounds, in addition to being a likely target of formamidine insecticides.
Keywords




This article is from Insect Biochemistry and Molecular Biology 63 (2015): 47, doi:10.1016/j.ibmb.2015.04.008.
Rights
Works produced by employees of the U.S. Government as part of their official duties are not copyrighted
within the U.S. The content of this document is not copyrighted.
Authors
Aaron D. Gross, Kevin G. Temeyer, Timothy A. Day, Adalberto A. Pérez de León, Michael J. Kimber, and Joel
R. Coats
This article is available at Iowa State University Digital Repository: http://lib.dr.iastate.edu/ent_pubs/302
Pharmacological characterization of a tyramine receptor from the
southern cattle tick, Rhipicephalus (Boophilus) microplus
Aaron D. Gross a, b, 2, Kevin B. Temeyer c, Tim A. Day b, Adalberto A. Perez de Leon c,
Michael J. Kimber b, 1, Joel R. Coats a, *, 1
a Pesticide Toxicology Laboratory, Department of Entomology, Iowa State University of Science and Technology, Ames IA 50011, USA
b Department of Biomedical Science, Iowa State University of Science and Technology, Ames IA 50011, USA
c Knipling-Bushland United States Livestock Insects Research Laboratory and Veterinary Pest Genomics Center, United States Department of Agriculture-
Agricultural Research Service, Kerrville, TX 78028, USA
a r t i c l e i n f o
Article history:
Received 16 February 2015
Received in revised form
21 April 2015
Accepted 27 April 2015








a b s t r a c t
The southern cattle tick (Rhipicephalus (Boophilus) microplus) is a hematophagous external parasite that
vectors the causative agents of bovine babesiosis or cattle tick fever, Babesia bovis and B. bigemina, and
anaplasmosis, Anaplasma marginale. The southern cattle tick is a threat to the livestock industry in many
locations throughout the world. Control methods include the use of chemical acaricides including
amitraz, a formamidine insecticide, which is proposed to activate octopamine receptors. Previous studies
have identiﬁed a putative octopamine receptor from the southern cattle tick in Australia and the
Americas. Furthermore, this putative octopamine receptor could play a role in acaricide resistance to
amitraz. Recently, sequence data indicated that this putative octopamine receptor is probably a type-1
tyramine receptor (TAR1). In this study, the putative TAR1 was heterologously expressed in Chinese
hamster ovary (CHO-K1) cells, and the expressed receptor resulted in a 39-fold higher potency for
tyramine compared to octopamine. Furthermore, the expressed receptor was strongly antagonized by
yohimbine and cyproheptadine, and mildly antagonized by mianserin and phentolamine. Tolazoline and
naphazoline had agonistic or modulatory activity against the expressed receptor, as did the amitraz
metabolite, BTS-27271; however, this was only observed in the presence of tyramine. The southern cattle
tick's tyramine receptor may serve as a target for the development of anti-parasitic compounds, in
addition to being a likely target of formamidine insecticides.
© 2015 Elsevier Ltd. All rights reserved.
1. Introduction
The southern cattle tick (Rhipicephalus (Boophilus) microplus) is
an ectoparasite that can have an economically devastating effect on
the cattle industry worldwide (Grisi et al., 2014). R.microplus, in the
United States, was estimated to have direct costs of more than $130
million to the cattle industry in 1906, which has been estimated to
be over $3 billion today (USDA-APHIS August 2010). The signiﬁcant
economic impact of this tick is realized with the diseases that it is
capable of vectoring. Speciﬁcally, the southern cattle tick is capable
of vectoring the apicomplexan protozoa Babesia bovis and B. bige-
mina, which cause bovine babesiosis, and the rickettsia Anaplasma
marginale that causes anaplasmosis (Perez de Leon et al., 2012;
Perez de Leon et al., 2014).
The United States initiated the Cattle Fever Tick Eradication
Program (CFTEP) in 1906, which eliminated the southern cattle tick
(R. microplus) and the cattle fever tick (R. annulatus) from thirteen
southern states by 1941 (Perez de Leon et al., 2012). Themainstay of
the CFTEP is the use of chemical acaricides; speciﬁcally, the organ-
ophosphate coumaphos. However, internationally several chemical
acaricides, with different mechanisms of action, have been used to
control the southern cattle tick, and has predictably resulted in
acaricide resistance. Acaricide resistance, particularly with tick
strains found in theAmericas, has been reported for several chemical
classes including organophosphates (Miller et al., 2005; Rodriguez-
Vivas et al., 2007; Temeyer et al., 2007; Miller et al., 2008; Guerrero
et al., 2012), synthetic pyrethroids (Li et al., 2007;Miller et al., 2007a;
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Cossio-Bayugar et al., 2008; Guerrero and Nene, 2008; Rosario-Cruz
et al., 2009) and formamidines (Li et al., 2007; Miller et al., 2007b;
Corley et al., 2013). Recently, a population of R. microplus of
concern has been discovered in Mexico. This population is resistant
to synthetic pyrethroids, organophosphates, amitraz (formamidine)
and ivermectin (macrocyclic lactone family) (Fernandez-Salas et al.,
2012). The permanent quarantine zone in south Texas along the
TexaseMexico border is part of the continued effort by the CFTEP to
keep the U.S. free of cattle fever ticks and bovine babesiosis. As
R. microplus is endemic to Mexico, there is the possibility of regular
reintroduction of the southern cattle tick into the U.S. Reintro-
duction is possible with the movement of cattle into the U.S. from
Mexicoand the abilityof the tick to bemaintainedonwildungulates.
For continued success of the CFTEP, it is imperative that integrative
pest control measures are taken, that new biochemical targets for
tick control are identiﬁed and a greater understanding of the
mechanism(s) of acaricide resistance (Temeyer et al., 2012; Perez de
Leon et al., 2012; Guerrero et al., 2014).
Octopamine and tyramine are biogenic amines found in a many
of invertebrates, including insects and ticks, and have been shown
to be involved in different physiological functions in insects. These
physiological functions are realized when octopamine or tyramine
activates their cognate receptor, which are G-protein-couple re-
ceptors (GPCRs) (Guerrero and Dowd, 2010). Octopamine and
tyramine are characterized as neurotransmitters, neurohormones
and neuromodulators (Roeder et al., 2003; Roeder, 2005; Farooqui,
2012; Ohta and Ozoe, 2014). While the diverse physiological
functions of octopamine have been realized for some time, we are
only starting to understand the physiological relevance of tyra-
mine; this is because, until recently, tyramine was thought to only
be a synthetic precursor to octopamine (Guerrero and Dowd, 2010;
Roeder et al., 2003; Roeder, 2005; Verlinden et al., 2010; Farooqui,
2012). Octopamine receptors are believed to be the target of for-
mamidine insecticides/acaricides, which include chlordimeform
and amitraz (Blenau et al., 2012; Hashemzadeh et al., 1985). Hy-
peractivity and tick detachment are symptoms of exposure to sub-
lethal concentrations of formamidine acaricides against the
southern cattle tick (Stone et al., 1974).
A cDNA sequence (AJ010743.1), originally thought to code for an
octopamine receptor, was isolated from two strains of R. microplus
ticks that were susceptible and resistant to amitraz in Australia.
However, the identiﬁed open reading frame (ORF) did not result in
any point mutations (Baxter and Barker, 1999). The putative
octopamine receptor was later identiﬁed in tick populations from
the Americas (EF490687.1 and EF490688.1) (Chen et al., 2007).
Additionally, two point mutations, T8P and L22S, were identiﬁed in
this putative receptor's open reading frame obtained from amitraz-
resistant ticks (EF490688.1). These point mutations were hypoth-
esized to have a possible role in the resistance to the acaricide
amitraz (Chen et al., 2007). However, the functional identiﬁcation
of these receptors ligands has yet to be performed. In fact, it has
been hypothesized, based on sequence similarity, that the origi-
nally identiﬁed receptor is a tyramine receptor, instead of an
octopamine receptor (Verlinden et al., 2010; Farooqui, 2012). The
objectives of this study were to (1) functionally characterize the
putative tyramine receptor from the southern cattle tick, and (2)
determine the receptor pharmacology using functional assays.
2. Materials and methods
2.1. Chemicals
Pharmacological analysis was performed with compounds
purchased from SigmaeAldrich (St. Louis, MO) unless otherwise
noted. Test compounds include tyramine hydrochloride (98%), DL-
octopamine hydrochloride (99%), (±)-synephrine, dopamine hy-
drochloride (98.5%), DL-norepinephrine hydrochloride (97%),
serotonin hydrochloride (5-hydroxytryptamine, 5-HT),
(±)-epinephrine hydrochloride, histamine dihydrochloride (99%),
phentolamine hydrochloride (98%), yohimbine hydrochloride
(98%), clonidine hydrochloride (solid), mianserin hydrochloride,
(±)-propranolol hydrochloride (99%), chlorpromazine hydro-
chloride (98%), amitraz metabolite BTS-27271 (N-(2,4-
Dimethylphenyl)-N0-methylformamidine, N-Methyl-N0-2,4-
xylylformamidine) Pestanal® (Fluka), naphazoline hydrochloride,
2-benzylimidazoline (tolazoline).
Test compounds were prepared fresh for each testing procedure
with the exception of the amitrazmetabolite BTS-27271, which was
used from frozen DMSO stocks. Tyramine and octopamine were
prepared in Hank's Balance Salt Solution (HBSS, Life Technologies,
Carlsbad, CA). The remaining compounds were dissolved in DMSO
then serially diluted with HBSS. The cells were exposed to a ﬁnal
concentration of 0.1% DMSO.
2.2. Putative tyramine receptor
The wild-type putative tyramine receptor (EF490687.1) was
isolated from the Gonzalez strain of tick (amitraz-susceptible). The
Gonzalez strain of R. microplus was originally identiﬁed in Zapata
County, Texas in 1984, and has been maintained in culture by the
USDA-ARS Knipling-Bushland U.S. Livestock Insects Research Lab-
oratory (KBUSLIRL), Kerrville, TX at the USDA-ARS Cattle Fever Tick
Research Laboratory (CFTRL), Edinburg, TX (Chen et al., 2007). The
receptor cDNAwas synthesized by GeneScript USA Inc. (Piscataway,
NJ) and cloned into a pCDNA3.1() expression vector (Life
Technologies).
2.3. CHO cell culture, transfection and calcium mobilization assay
Cell culture materials were obtained from Life Technologies,
unless otherwise stated. Chinese hamster ovary-K1 (CHO or CHO-
K1) cells were obtained from American Type Culture Collection
(ATCC; Manassas, VA). CHO cells were maintained in a NuAire hu-
midiﬁed water jacket incubator (Plymouth, MN); the incubator was
maintained at normal cell growth conditions of 37 C, 90% humidity
and 5% CO2. The normal cell growth medium consisted of 1X Ham's
F12K (Kaighn's modiﬁcation) medium supplement with 10 mM
HEPES (N-2-hydroxyethylpiperazine-N0-2-ethanesulfonic acid)
plus 10% fetal bovine serum (FBS) (Atlas Biologicals, Fort Collins,
CO). CHO cells were subcultured when cell conﬂuency reached
80%e90%. To subculture, cells were washed with Dulbecco's
Phosphate Buffered Saline (DPBS); then cells were detached from
culturing ﬂasks with 0.25% trypsine 0.53mM EDTA (trypsin-EDTA)
solution. Cells were then centrifuged at 900  g for 5 min at room
temperature; cell pellet was resuspended in fresh normal cell
growth media.
Transient transfection of CHO cells with the putative tyramine
receptor was performed in 6-well cell culture plates (Corning). Cells
were transfected using Lipofectamine 2000® in OPTI-MEM sup-
plement with F12K þ 10% FBS, according to the manufacturer's
protocols (Invitrogen). Cells were transfected with 2.5 mg of vector
DNA, which allowed the examination of the putative tyramine re-
ceptor's ability to link to the endogenous calcium pathway (Gaq).
CHO cells were also transfected with individual G-protein chimeras
(Gaqo5, Gaqi5, Gaqs5, or Gaqz5) to force receptor-mediated signaling
down the calcium-signaling pathway as previously described
(Conklin et al., 1996; Omar et al., 2007). CHO cells were incubated in
the transfection medium for 12 h at normal cell growth conditions.
After 12 h, cells were lifted from 6-well plate using trypsin-EDTA.
Cells were washed with normal growth medium and moved to a
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15-mL conical tube, and were centrifuged at 900  g at room
temperature for 5min. The cell pellet was resuspended in 3e3.5mL
of normal cell growth medium. CHO cells were counted using a
Countess® Automatic Cell Counter (Life Technologies), according to
themanufacturer's protocols. CHO cells were placed into black-wall
clear-bottom 96-well plates (Corning) at a cell density of 27,500
cells per well, with a total volume of 100 mL. Cells were incubated at
normal cell culture conditions for 24 h prior to performing the
calcium mobilization assay. The calcium mobilization assay was
performed with a Fluo-4 NWCalcium Assay Kit (Life Technologies),
according to the manufacturer's protocol. Brieﬂy, the cells were
incubated in HBSS, 20 mM HEPES, a calcium-sensitive ﬂuorescent
dye (Fluo-4) and 2.5 mM probenecid; cells were incubated in this
medium for 90 min at 37 C prior to the start of the assay. Fluo-
rescence was monitored using a FlexStation 1 (Molecular Devices,
Sunnyvale, CA). Fluorescence changes were monitored with exci-
tation at 494 nM and emission at 516 nM. Basal ﬂuorescence was
monitored for 20 s prior to the addition of screening compounds.
The ﬂuorescence readings were measured every 1.5 s for 120 s.
Stable transfection was performed using the transient trans-
fection procedure. However, instead of proceeding to the functional
assay, cells were maintained in medium containing 100 mg/mL of
Geneticin® (G418 sulfate; Corning). Single-cell colonies were
selected in 96-well plates over four weeks. Successfully transfected
cells, with both the putative tyramine receptor and G-protein
chimera, were determined with a calcium mobilization assay and
by RT-PCR.
Compounds were screened using an agonist and/or an antago-
nist screening method. The agonist screening method was utilized
with the addition of the potential agonist added by the FlexStation
after a 20-second background reading. Antagonist or modulator
screening was performed by preincubating the putative antagonist
or modulator with the cells in the black-walled clear-bottom 96-
well plate for 30 min prior to the addition of tyramine (addition
performed by the FlexStation).
2.4. Data analysis
A minimum of six wells per plate along with a minimum of four
plates was analyzed for each treatment. Additionally, each plate
contained several controls: a blank (calcium ﬂuorescent indicator,
probenecid (2.5 mM) and HBSS with 10 mM HEPES buffer), a
vehicle control, along with an autoﬂuorescent control (ﬂuorescent
indicator (Fluo-4), HBSS with 10 mM HEPES and the ligand).
Additionally, non-receptor mediated effects were monitored for
each treatment and consisted of untransfected cells not expressing
the receptor (regular CHO cells). Concentration-response curves
were analyzed in GraphPad Prism (La Jolla, CA). One-way ANOVA
and a paired t-test were used to test the data for statistically sig-
niﬁcant differences of agonist and antagonist compounds using SAS
9.3 (Cary, NC). Student-Newman-Keuls (SNK) post-hoc analysis was
used to determine signiﬁcant differences between treatments with
95% conﬁdence (a ¼ 0.05). Antagonist and modulator screening
results were normalized to 150 nM tyramine (100%), which is
represented as a dashed line in the appropriate ﬁgures.
3. Results
The putative tyramine receptor was successfully expressed in
Chinese Hamster Ovary (CHO) cells, and functional receptor acti-
vation was determined using a calcium-liberation assay. The
calcium-liberation assay analyzes receptor activation via the Gaq
phospholipase-C (PLC) pathway. Receptor activation results in an
increase of cytosolic calcium, which can be quantiﬁed using a
calcium-sensitive ﬂuorescent dye. However, not all receptors will
signal using the Gaq PLC pathway; therefore, a set of Gaq-protein
chimeras, which funnel receptor activation down the Gaq PLC
pathway resulting in an increase of intracellular calcium, were used
(Fig. 1). These G-protein chimeras were developed to have the
receptor-interacting domain (5 amino acids) from different
G-proteins (Gas, Gaz, Gai and Gao), built on the Gaq backbone to
make a hybrid calcium-sensitive signaling molecule designated as
Gaqs(5), Gaqz(5), Gaqi(5) and Gaqo(5). Therefore, heterologous
expression of a receptor with the Gaq chimera allows for quantiﬁ-
cation of receptor activation using a ﬂuorescence output (Fig. 1).
The R. microplus putative tyramine receptor was transiently
expressed in CHO cells alone to see if the receptor activated the
endogenous Gaq PLC pathway (Fig. 1). Expression of the receptor
alone resulted in a weak ﬂuorescent response to tyramine and
octopamine at 1 mM (Fig. 1). Transient expression was performed
with the putative tyramine receptor in combinationwith individual
Gaq chimeras (Gaqs(5), Gaqz(5), Gaqi(5) and Gaqo(5)). As shown in
Fig. 1, co-expression of the putative tyramine receptor resulted in
the most signiﬁcant response when co-expressed with the Gaqi(5)
G-protein chimera (Fig. 1). Additionally, 1 mM tyramine had a
stronger and more signiﬁcant ﬂuorescence response when
compared to 1 mM octopamine, which indicated that tyramine
preferentially activated the heterologously expressed receptor with
the Gaqi(5) G-protein chimera. Tyramine and octopamine displayed
concentration-dependent responses in CHO cells transiently
expressing the receptor along with the Gaqi(5) chimeric protein
(Fig. 2). Tyramine had an EC50 of 9 nM, whereas octopamine had an
EC50 of 351 nM; therefore, tyramine is 39-fold more effective at
activating the heterologously expressed receptor with the Gaqi(5)
chimera, compared to octopamine (Fig. 2 and Table 1). Additional
biogenic amines were screened at 1 mM to ensure that tyramine is
the preferred ligand. Tyramine activated the receptor most signif-
icantly, followed by octopamine. Acetylcholine, along with the N-
methylated analogue of octopamine, synephrine, were capable of
mildly activating the expressed receptor and Gaqi(5) chimera, but
not as signiﬁcantly as tyramine or octopamine (Fig. 3). Dopamine,
5-HT (serotonin), norepinephrine, epinephrine and histamine had
little effect against the expressed receptor and chimera at 1 mM
(Fig. 3). These results indicated that the originally classiﬁed
Fig. 1. Expression of RmTAR1 alone and in combination with G-protein chimeras.
Transient expression of the R. microplus tyramine receptor coding sequence alone
(endogenous Gaq) and in combination with G-protein chimeras (Gaqs(5), Gaqz(5),
Gaqo(5), Gaqi(5)) in CHO cells. Intracellular calcium concentrations were measured with
a calcium-sensitive ﬂuorescent indicator (relative ﬂuorescent units, RFU). Tyramine
and octopamine were screened at 1 mM to see which ligand strongly activated either
the receptor alone or the receptor in combination with speciﬁc G-protein chimeras.
Different letters indicate a statistically signiﬁcant response (ANOVA, a ¼ 0.05).
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putative octopamine receptor (referred to here as the putative
tyramine receptor) aligns with the proliferation of tyramine re-
ceptor sequence data to show the receptor is a tyramine receptor.
Speciﬁcally, this receptor appears to be a tyramine-1 receptor
(RmTAR1) (Ohta and Ozoe, 2014).
A colonial cell line that stably expressed the cattle tick tyramine
receptor and the Gaqi(5) chimera was established and selected over
several weeks. Efﬁciency of the stable transfection of both the
tyramine receptor and the G-protein chimera was approximately
8% (n ¼ 24). Tyramine resulted in a concentration-dependent
response of CHO cells stably expressing the tyramine receptor
and the Gaqi(5) chimera, which had an EC50 of 15 nM. This is similar
to CHO cells transiently expressing the tyramine receptor and the
Gaqi(5) chimera (Fig. 4 and Table 1).
The pharmacological toolbox to characterize octopamine re-
ceptors and tyramine receptors is limited. Adrenergic agonists and
adrenergic antagonists are commonly used to determine the
pharmacology of octopamine receptors and tyramine receptors. Six
antagonists (propranolol, chlorpromazine, mianserin, phentol-
amine, cyproheptadine and yohimbine) were screened at three
concentrations (0.1 mM,1 mM and 10 mM) to determine if they were
capable of antagonizing the receptor when the receptor was
stimulated with 150 nM tyramine (Fig. 5). Propranolol enhanced
the effect of 50 nM tyramine, but it was not statistically signiﬁcant
from tyramine alone (Fig. 5). Cyproheptadine and yohimbine were
the only compounds capable of antagonizing 150 nM of tyramine
signiﬁcantly at all three concentrations (0.1 mM, 1 mM and 10 mM)
tested (Fig. 5). Mianserin antagonized 150 nM of tyramine at 1 mM
and 10 mM (Fig. 5). Phentolamine antagonized only at 10 mM.
Yohimbine and phentolamine both antagonized the 1 mM tyramine
response in a concentration-dependent manner; however, yohim-
bine was 18-fold more effective at antagonizing the RmTAR1
compared to phentolamine (Table 2).
Compounds that were able to stimulate or act as agonists to the
RmTAR1 were also examined. Agonists tested include clonidine,
naphazoline and tolazoline, which were screened at 0.1 mM, 1 mM
and 10 mM to see if they activated RmTAR1, compared to the same
Fig. 2. Concentration-dependent response of transiently expressed RmTAR1 plus
Gaqi(5). Concentration-dependent response of the expressed coding sequence of the
R. microplus tyramine receptor and the Gaqi(5) G-protein chimera with several con-
centrations of tyramine (solid black line) and octopamine (solid gray line). These two
biogenic amines were used to monitor the increase of intracellular calcium, using a
calcium-sensitive ﬂuorescent dye, measured by relative ﬂuorescence units (RFU). CHO
cells not transfected with the receptor were screened at various concentrations of
tyramine (dashed gray line). Data analyzed using GraphPad Prism ECanything (F ¼ 50
or EC50).
Table 1
EC50 of tyramine and octopamine. This table shows the EC50 for the concentration-
dependent response of tyramine. The values were obtained when an R. microplus
tyramine receptor and the Gaqi(5) G-protein chimera were transiently and stably
transfected in CHO cells. Tyramine's activation of the receptor resulted in the in-
crease of intracellular calcium concentration, which was measured using a calcium-
sensitive ﬂuorescent dye.
EC50 ± SEM 95% CI
Tyramine (transient) 9 ± 0.9 nM (0.1 nM, 764 nM)
Octopamine (transient) 351 ± 2 nM (302 nM, 1476 nM)
Tyramine (stable) 15 ± 7 nM (5 nM, 60 nM)
Fig. 3. Effect of biogenic amines against RmTAR1. Several biogenic amines were
examined to determine if they activated the expressed receptor and increased the
intracellular concentration of calcium by using a calcium-sensitive ﬂuorescent dye that
was measured in relative ﬂuorescence units (RFU). Two-way ANOVA (a ¼ 0.05)
different letters indicate a signiﬁcant difference.
Fig. 4. Tyramine concentration-dependent response of CHO cells transiently and sta-
bly expressing RmTAR1 plus Gaqi(5). Concentration-dependent response of the
expressed coding sequence of the R. microplus tyramine receptor and the Gaqi(5) G-
protein chimera. This concentration-dependent response compared CHO cells tran-
siently expressing the Gaqi(5) G-protein chimera (solid black), and CHO cells stably
expressing the R. microplus tyramine receptor with the Gaqi(5) G-protein chimera
(dashed gray). CHO cells not transfected with the receptor were screened at various
concentrations of tyramine (dashed black line). Data analyzed using GraphPad Prism
ECanything (F ¼ 50 or EC50).
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concentrations of tyramine (Fig. 6). Clonidine, naphazoline and
tolazoline did not signiﬁcantly agonize RmTAR1 to the same level as
tyramine (Fig. 6). Naphazoline and tolazoline were able to partially
agonize RmTAR1 at 10 mM, just not as strongly as tyramine itself.
Clonidine, naphazoline and tolazoline were also screened as an-
tagonists or modulators of the tyramine receptor. This was per-
formed by preincubating these compounds for 30 min prior to the
addition of 150 nM tyramine. Tolazoline and naphazoline signiﬁ-
cantly enhanced the 150 nM response of tyramine at all three
concentrations (0.1 mM, 1 mM and 10 mM), as shown in Fig. 7.
Previously, this putative tyramine receptor had been hypothe-
sized to be involved in resistance to the chemical acaricide amitraz,
which is a formamidine insecticide/acaricide. Amitraz's metabolite,
BTS-27271, was screened at 10 mM and 100 mM and signiﬁcantly
increased the150 nM-tyramine response by 191 ± 16% and
150 ± 24%, respectively. This agonistic activity was only observed in
the presence of 150 nM tyramine (Fig. 8).
4. Discussion
Reintroduction of R. microplus into the United States would have
devastating consequences to the livestock industry. To aid in an
integrative chemical approach to controlling the southern cattle
Fig. 5. Antagonist screening against CHO cells stably expressing RmTAR1 and Gaqi(5)
G-protein chimera. Antagonists were pre-incubated for 30 min prior to the addition of
tyramine, which was added at 150 nM. The effect of the antagonist was normalized to
this 150 nM tyramine response (100%, dashed line). Data was analyzed using a one-
way ANOVA (a ¼ 0.05). An asterisk indicates a statistically signiﬁcant antagonistic
effect, compared to the addition of150 nM tyramine alone.
Table 2
IC50 of yohimbine and phentolamine. This table shows the IC50 for the
concentration-dependent inhibition of receptor activation, normalized to 1 mM
tyramine. The values were obtained with an R. microplus tyramine receptor and the
Gaqi(5) G-protein chimera that were stably transfected in CHO cells.
IC50 ± SEM 95% CI
Yohimbine 280 ± 151 nM (73 nM, 1070 nM)
Phentolamine 5156 ± 969 nM (118 nM, 2.26  105 nM)
Fig. 6. Agonist screening against CHO cells stably expressing RmTAR1 and Gaqi(5) G-
protein chimera. Agonist screens were done in real time to determine if they were able
to increase the intracellular concentration of calcium, which was detected by a
calcium-sensitive ﬂuorescent indicator. Agonist screening was performed at three
concentrations (0.1 mM, 1 mM, and 10 mM). An asterisk indicates a statistically signiﬁ-
cant agonistic effect, compared to the respective concentration of tyramine.
Fig. 7. Screening of agonists/modulators against RmTAR1. Agonist or modulators were
preincubated for 30 min prior to the addition of 150 nM of tyramine (dashed line). The
response of the agonist or modulator was normalized to tyramines response (dashed
line) Screening against CHO cells stably expressing RmTAR1 and Gaqi(5) G-protein
chimera. Agonist screens were done in real time to determine if they were able to
increase the intracellular concentration of calcium. Screening was performed at three
concentrations (0.1 mM, 1 mM, and 10 mM). An asterisk indicates a statistically signiﬁ-
cant effect, compared to addition of 150 nM tyramine alone.
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tick, research is required to understand mechanisms of acaricide
resistance, and to identify new chemistries that either target
known mechanisms of action or identify new mechanisms of toxic
action. The results shown here indicate that nucleic acid sequence
originally thought to code for an octopamine receptor from
R. microplus is actually a tyramine receptor. Additionally, functional
assays showed that when this tyramine receptor was co-expressed
with the Gaqi(5) chimera it resulted in themost signiﬁcant response.
The Gaqi(5) uses the Gai receptor interacting domain; it is likely that
this tyramine receptor would signal down the pathway that has an
inhibitory effect on adenylate cyclase, thereby, decreasing the
intracellular concentration of cAMP.
Recent reviews have hypothesized, based on sequence data, that
this receptor is a TAR1 (this class was previously known as octop-
amine/tyramine or tyramine receptor), which would normally
signal through the Gai pathway (Ohta and Ozoe, 2014; Verlinden
et al., 2010; Farooqui, 2012). Several TAR1 receptors have been
identiﬁed and second messenger pathways analyzed from Apis
mellifera, AJ245824 (Blenau et al., 2000), Bombyx mori, AB162828
(Ohta et al., 2003), Chilo Suppressalis, JQ416145 (Wu et al., 2013),
Drosophila melanogaster, X54794 (Saudou et al., 1990), Heliothis
virescens, X95606 (von Nickisch-Rosenegk et al., 1996), Locusta
migratoria, X69520 (Vanden Broeck et al., 1995) and Periplaneta
americana, AM990461 (Rotte et al., 2009).
Pharmacological characterization of tyramine receptors, like
octopamine receptors, is performed with agonists and antagonists
used for the mammalian adrenergic system. Yohimbine is a known
a2-adrenergic antagonist, and has previously been shown to be
effective at blocking the inhibitory effect of tyramine on forskolin-
stimulated cAMP in heterologous expression systems (Ohta et al.,
2003; Rotte et al., 2009; Wu et al., 2013). Rotte et al. (2009)
found that yohimbine produced the strongest antagonistic effect,
followed by chlorpromazine then cyproheptadine. However, we
ﬁnd that yohimbine and cyproheptadine produce the strongest
antagonistic effect, at the three tested concentrations, followed by
mianserin (signiﬁcant antagonism at 1 mM and 10 mM), then fol-
lowed by phentolamine (signiﬁcant at 10 mM). Phentolamine is
widely accepted as a more efﬁcient antagonist for octopamine re-
ceptors than for tyramine receptors (Roeder, 2005), which is
consistent with our results.
The tyramine receptor described here was also investigated for
its potential role in amitraz resistance observed in southern cattle
tick populations fromAustralia and theAmericas (Baxter andBarker,
1999; Chen et al., 2007). The ﬁrst identiﬁcation of the tyramine re-
ceptor was in Australia, and no point mutations were discovered in
the amitraz-resistant strain compared to the amitraz-susceptible
strain (Baxter and Barker, 1999). However, the Santa Luiza and San
Alfonso strains of southern cattle tick display two point mutations
(T8P and L22S), and these ticks are resistant to amitraz (Chen et al.,
2007). This was hypothesized to have a role in formamidine resis-
tance, and this is currently the topic of ongoing studies in our lab-
oratory. Recent studies have reinstated the Australian Rhipicephalus
tick as a separate species, Rhipicephalus (Boophilus) australis (Fuller,
1899) present in Australia, Southeast Asia and Indonesia (Estrada-
Pe~na et al., 2012, Barker et al., 2014; Burger et al. 2014). Separation
of the Australian and American ticks into separate species suggests
potential differences in mechanisms for development of amitraz
resistance between the two species as it has been documented for
pyrethroid resistance (Guerrero et al., 2014).
Octopamine receptor(s) are believed to be the primary target of
formamidine metabolites, including amitraz's metabolite BTS-
27271. Demethylchlordimeform (chlordimeform's metabolite) did
not have an effect on forskolin-stimulated cAMP on B. mori's tyra-
mine receptor when expressed in HEK-293 cells (Ozoe et al., 2004).
We also did not see any effect of amitraz's metabolite alone (data
not shown); however, signiﬁcant receptor activation was observed
when applied in combination with 150 nM tyramine (Fig. 7). This
indicates that BTS-27271 can have an effect at the tyramine re-
ceptor but probably only when the tyramine receptor is activated.
Given the emerging evidence that populations around the world
may constitute a species complex, having an understanding of
amitraz-resistance may aid in adapting strategies to control of
southern cattle ticks. Recently, a mutation in a putative R. microplus
b-adrenergic-like octopamine receptor has been hypothesized to
have a role in amitraz-resistance (Corley et al., 2013). However,
functional receptor and functional resistance assays have not been
conducted against this octopamine receptor to date.
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Fig. 8. Amitraz metabolite's effect on RmTAR1 and Gaqi(5). The metabolite of amitraz
(BTS-27271) was screened against CHO cells stably expressing RmTAR1 and Gaqi(5) G-
protein chimera at two concentrations (10 mM and 100 mM). The metabolite was added
30 min prior to the addition of 150 nM tyramine. The response of the metabolite was
normalized to tyramines effect (dashed line). An asterisk indicates a statistically sig-
niﬁcant effect, compared to the addition of 150 nM tyramine alone.
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